Oncoinvent opens new facilities
Yesterday, Oncoinvent held an opening ceremony for its new production and lab facilities.
The new production facility contains a Grade B clean room, two Category B type isotope production suites, a quality control laboratory, and packaging area that will support qualified operations for manufacturing, analytical control, packaging and labelling of Radspherin for upcoming preclinical and clinical studies.
"This event marks a highlight in a year that has seen tremendous growth in the company. The opening of our new laboratory and production facilities represents a significant achievement for the company and will enable the company to move Radspherin® rapidly into the next phase of development in 2018," said Jan A. Alfheim, Oncoinvent's CEO.
Yesterday, Oncoinvent held an opening ceremony for its new production and lab facilities.
The new production facility contains a Grade B clean room, two Category B type isotope production suites, a quality control laboratory, and packaging area that will support qualified operations for manufacturing, analytical control, packaging and labelling of Radspherin for upcoming preclinical and clinical studies.
“This event marks a highlight in a year that has seen tremendous growth in the company. The opening of our new laboratory and production facilities represents a significant achievement for the company and will enable the company to move Radspherin® rapidly into the next phase of development in 2018,” said Jan A. Alfheim, Oncoinvent’s CEO.
Published: December 14, 2017
